breast cancer

Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe

Read more

Israeli scientists find promising target for breast cancer and other cancer therapeutics

Read more

Sanofi partners with BIG, EORTC, AFT to study amcenestrant for ER+ breast cancer treatment

Read more

NATCO gets US FDA nod for Everolimus tablets  

Read more

USFDA denies application from SPARC for cancer drug

Read more

New potential breast cancer drug identified

Read more

Alembic Pharma gets USFDA tentative nod for Palbociclib Capsules

Read more

Global HER2-positive breast cancer market to face challenges from biosimilars through to 2025

Read more

Cattle virus linked to breast cancer

Read more

Targeted therapies offer novel treatment modalities for breast cancer: Frost & Sullivan

Read more